Pharmafile - Medical Communications News
Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical...
“In the life sciences industry, we see a shift toward transparency and collaboration,” says Robert Groebel, Vice President of Medical Strategy at...
New research has argued that GPs in the UK are lacking the skills needed to adequately handle chronic opioid use in their patients, and the...
The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical...
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
A long-acting, injectable HIV drug combo is to be tested in a clinical trial of 350 volunteers with HIV.
Bristol-Myers Squibb’s Opdivo failed its primary endpoint in a Phase 3 trial investigating its efficacy in the treatment of newly diagnosed O6-...
Gilead Sciences has agreed to donate 11 years’ worth PrEP drugs for up to 200,000 individuals each year, following “discussions between the Trump...
Nearly 5,000 EU nurses and midwives have left the NHS over the past two years.
Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal worth as much as $5.3...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
